TRV News and Press, The Travelers Companies Inc. From 05/03/24

2024-05-03 01:38:02 ET Summary Expected dividend increases in May 2024 for Cardinal Health, Lowe's Companies, Medtronic, Chubb Limited, and LyondellBasell Industries N.V. 2 Dividend Aristocrats and 1 Dividend Kings are featured in this article. Two Big Tech companies, Apple an...

The Travelers Companies, Inc. (NYSE: TRV ) today announced the opening of an office in Midtown Atlanta’s Technology Square. The location will support the company’s expanding technology organization, with roles in engineering, artificial intelligence and data science, among other...

2024-04-30 03:45:00 ET Summary Comments and outlooks provided in earnings reports can reveal crucial information about a company’s health and prospects. Insights from management teams are invaluable. When they indicate trends, such as auto insurance pricing remaining high i...

2024-04-29 08:31:45 ET Summary Eleven long-term dividend growth companies announced their annual dividend increases in the second half of April. Investors were rewarded with 10%+ increases from Grainger and Parker-Hannifin. Another 12 long-term dividend growth companies should...

2024-04-20 09:53:05 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...

2024-04-18 12:10:43 ET Bearish sentiment among individual investors about the short-term outlook for the stock market rose amid uncertainty regarding Federal Reserve’s interest rate cuts and sentiments around several earnings report cards.... Read the full article on Seeking Al...

2024-04-17 17:30:03 ET Goldman Sachs analyst issues SELL recommendation for TRV on April 17, 2024 03:48PM ET. The previous analyst recommendation was Sell. TRV was trading at $206.58 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Curren...

2024-04-17 17:00:03 ET Alex Scott from Goldman Sachs issued a price target of $202.00 for TRV on 2024-04-17 15:48:00. The adjusted price target was set to $202.00. At the time of the announcement, TRV was trading at $206.58. The overall price target consensus is at $198....

2024-04-17 12:47:07 ET The Travelers Companies, Inc. (TRV) Q1 2024 Earnings Conference Call April 17, 2024, 09:00 AM ET Company Participants Abbe Goldstein - SVP, IR Alan Schnitzer - Chairman & CEO Dan Frey - CFO Gregory Toczydlowski - President, Business...

2024-04-17 11:27:00 ET Summary Eli Lilly's tirzepatide reached main goals in two Phase 3 trials for patients with obesity and obstructive sleep apnea. Abbott posts Q1 results beat, Travelers earnings hurt by elevated catastrophe losses. Mortgage servicing within housing-financ...